Liver Biopsy

Brief summary: A liver biopsy is a diagnostic procedure in which a small tissue sample is taken from the liver and examined under a microscope. It is not required in every liver disease; in selected situations it is used for diagnosis, staging, or treatment planning.

What is a liver biopsy?

A liver biopsy is a diagnostic procedure in which a small sample of liver tissue is obtained and examined in a pathology laboratory. The tissue sample can provide information about inflammation, steatosis, fibrosis, cirrhosis, tumor, drug-related injury, or other liver diseases. Although non-invasive methods such as blood tests and elastography have advanced considerably, in some situations tissue diagnosis can still remain the most reliable source of information. ^{[1][2][3][5][6]}

A biopsy is not automatically performed for every abnormal liver test. Physicians usually first try to approach the diagnosis with blood work, viral hepatitis studies, ultrasound, or other imaging. If these methods are insufficient or if clarifying disease severity would change treatment, biopsy may come onto the agenda. For that reason, liver biopsy is not a purposeless procedure; it is a targeted tool used in selected situations to answer a specific diagnostic question. ^[1][2][3][4]

Why is it performed?

Liver biopsy may be used in unexplained elevation of liver tests, staging of chronic hepatitis, determining the severity of fatty liver disease, distinguishing autoimmune or metabolic liver disorders, evaluating certain masses or focal lesions in the liver, and sometimes in post-transplant follow-up. The core goal is not only to answer whether disease is present, but also what type of disease it is, how extensive it is, and whether it will change treatment. ^{[1][2][3][5][7]}

It becomes particularly important when non-invasive tests give conflicting results, when more than one cause of liver disease may be present, or when the degree of fibrosis will alter management. Even so, it is not necessary for every patient, because the procedure is invasive and does carry some risk of complications. The biopsy decision in hepatology therefore requires balancing the likely information gained against the risk of the procedure. ^[1][3][4][6]

What types of liver biopsy are there?

The most commonly used method is percutaneous biopsy, meaning tissue is sampled with a needle through the skin. In addition, in patients at higher bleeding risk or in special situations, transjugular biopsy may be preferred; in that method, the liver is reached through a vein in the neck. In some cases, biopsy is targeted to a focal lesion under imaging guidance. The choice of method depends on coagulation status, the presence of ascites, coexisting illnesses, and the purpose of the biopsy. ^[1][2][3][5]

The importance of selecting the right method lies in the fact that it directly affects safety. For example, a standard percutaneous approach may not be suitable in patients with marked coagulation abnormalities or substantial abdominal fluid. A liver biopsy should therefore not be viewed as a single technique, but rather as a group of individualized procedures with different access routes. ^[1][3][4]

How is preparation done before the procedure?

Before the procedure, blood count, coagulation tests, and sometimes imaging are reviewed again. If blood-thinning medication is being used, the timing of stopping it must be planned by the procedure team. The patient is informed about fasting requirements, whether someone should accompany them on the day of the procedure, and how long observation will continue afterward. It is also important to share any previous history of bleeding, fainting, or complications after procedures. ^[1][2][3][4]

One of the most important points before biopsy is that the patient understands why the procedure is being done. This is because biopsy is usually performed not simply to obtain a report, but to clarify diagnosis and treatment decisions. If the expected informational gain is not clear, the necessity of the procedure may need to be reconsidered. This approach both reduces unnecessary interventions and facilitates informed consent. ^[1][3][6]

What happens during and after the procedure?

In percutaneous liver biopsy, the skin is usually numbed with local anesthesia and a tissue sample is quickly obtained with a needle under imaging guidance. The procedure itself does not usually take long, but observation for a period afterward is necessary. This is mainly because complications such as bleeding or pain are most likely to appear in the first hours. The patient may be asked to rest in a certain position for some time. ^[1][2][3][5]

Mild shoulder pain or right upper abdominal discomfort may occur after the procedure and is often short-lived. However, pain that progressively worsens, low blood pressure, dizziness, or shortness of breath are not considered normal. The time at which the patient can go home and when medications can be restarted are planned individually. ^[1][2][3]

What are the risks and complications?

Although liver biopsy is generally considered safe, the most important complication is bleeding. Other possible issues include pain, bile leak, infection, injury to nearby organs, and, more rarely, serious systemic complications. The fact that risk is low does not mean the procedure is risk-free; method selection and preparation are especially critical in people with coagulation problems. ^{[1][3][5][6][7]}

Even though the risk of bleeding is uncommon, it should not be dismissed as unimportant. Prolonged abdominal pain after biopsy, pain radiating to the shoulder, faintness, pallor, and rapid pulse can all be warning signs of bleeding. For that reason, alarm symptoms should be explained clearly before discharge. ^[2][3][4]

How are the results interpreted and when should a doctor be contacted?

A biopsy result is usually not reported simply as present or absent; it may include details such as the degree of inflammation, fat accumulation, fibrosis stage, iron deposition, bile-duct changes, or tumor characteristics. For that reason, reading the report independently of the clinical context can be misleading. The best interpretation is obtained when the biopsy result is evaluated together with blood tests, imaging, and the patient’s symptoms. ^[1][2][3][4]

If increasing abdominal pain, shortness of breath, dizziness, marked weakness, fever, bleeding from the biopsy site, or abdominal distention develops after the procedure, prompt assessment is required. These symptoms may be early signs of complications. Although most patients recover without problems, the safest approach is to take alarm findings seriously. ^[2][3][4]

The decision for liver biopsy should be made together with blood tests, imaging, and clinical history. If increasing abdominal pain, shortness of breath, feeling faint, or bleeding develops after the procedure, urgent medical assessment is needed.